BPIQ Blog

$XBI $127.74 -3.16% Covid Updates $HGEN -3.6% Humanigen Announces the European Medicines Agency Has Appointed a Rapporteur and ...

$XBI $131.91 +1.50% Covid Updates $NRXP +6.8% NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19...

$XBI $130.37 -2.03% Pipeline Updates $OPK -3.4% Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application...

$XBI $133.07 +1.88% Pipeline Updates $VTVT +19.2% vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development...

$XBI $130.62 +0.28% Covid Updates $GILD -0.5% Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients...

$XBI $130.25 +1.16% Pipeline Updates $BLUE +0.1% bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene...

$XBI $128.76 -3.10% Covid Updates $EIGR -2.5% Eiger BioPharmaceuticals Announces Interim Analysis and Continuation of Dosing of...

$XBI $133 +1% Covid Updates $PFE -1% FDA ADVISORY COMMITTEE VOTES UNANIMOUSLY IN FAVOR OF COMIRNATY® BOOSTER FOR EMERGENCY USE IN PEOPLE...

$XBI $131.00 +0.40% Covid Updates $ABCL +5.3% Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with...

$XBI $130.43 +1.0% Pipeline Updates $BTAI -0.1%BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination...

$XBI $128.99 -1.59% Covid Updates $RDHL -32.7% RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19...

$XBI $131.08 -0.50% Covid Updates $TNXP -0.80% Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-1800 as a...

$XBI $132 -2% Covid Updates $NVAX Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of...

$XBI $132.82 +0.39% Covid Updates $HGEN -47.3% FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in...

$XBI $132.31 -0.87% Covid Updates $NVAX -1.4% Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and...

$XBI $133.47 -0.70% Covid Updates $BNTX $PFE +3.7% Submit a Variation to EMA with the Data in Support of a Booster Dose of COMIRNATY®....

$XBI $134 -2% Covid Updates $CYDY +3% CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and...

$XBI $136.53 +1.07% Covid Updates $SRNE +0.1% Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for...

$XBI $135.08 +1.70% Covid Updates $RIGL +8.2% Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19...

$XBI $132.84 +0.92% Pipeline Updates $EGRX +10.2% Eagle Pharmaceuticals Wins Vasopressin Patent Trial. source $PSTX -19.3% Poseida...